Project Grant HT94252510602
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$649K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
The Defense Health Agency awarded Rutgers, The State University of New Jersey a $942,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support targeted chemotherapeutic and immunotherapeutic research for drug-resistant ovarian cancer. The three-year award beginning April 1, 2023 will fund Rutgers Biomedical and Health Sciences' investigation into medical solutions for this treatment-resistant form of ovarian cancer through innovative research...
Rutgers The State University of New Jersey, doing business as Rbhs-School of Nursing, was awarded a $783,077 Project Grant from the Defense Health Agency on May 1, 2023 to complete the project by April 30, 2026. The grant supports research titled "Defining the Cell Cycle Phase-Specific Regulation and Function of MTORC1 to Identify New Therapeutic Targets in TSC Tumors" under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and...
Rutgers The State University Of New Jersey, doing business as Rbhs-School Of Nursing, was awarded a $785,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund development of new therapeutic strategies for chemo brain in ovarian cancer survivors from July 1, 2023 through June 30, 2027. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
The Defense Health Agency awarded Rutgers, The State University a $471,000 project grant under the Military Medical Research and Development program (CFDA 12.420) to develop new therapeutic strategies for chemo brain in ovarian cancer survivors. The grant period runs from July 1, 2023 through June 30, 2027 in New Brunswick, New Jersey. Through its Research Financial Services division, Rutgers will leverage its expertise in bioengineering and disease research to investigate medical solutions...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $768,420.00 to Rutgers, The State University of New Jersey's Cancer Institute to conduct research on rewiring very long chain fatty acid metabolism in pancreatic tumor-associated macrophages. The goal is to overcome resistance to KRAS-targeted therapy in pancreatic cancer. The award period runs from July 1, 2025 to June 30, 2028. The research aims to...
The Department of the Army Medical Command awarded Rutgers, The State University of New Jersey a $751,587 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research targeting adenosine kinase for the prevention of post-traumatic epilepsy from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health...
The federal Block Grant award of $824,250 was provided by the Defense Health Agency to Rutgers, The State University of New Jersey, to support the Lung Cancer Research Program. This award, under the Military Medical Research and Development program (CFDA 12.420), will fund innovative biomedical research projects at Rutgers focused on improving health outcomes for military service members, veterans, and the broader public. Rutgers, leveraging its expertise in medicine, nursing, public health, and...
This Project Grant award of $894,125.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to understand and target epigenetic vulnerabilities in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors (NF1-MPNST) at Washington University. The research aims to transform healthcare for military service members, veterans, and the public by investigating innovative medical solutions. The 3-year...
The Defense Health Agency awarded a $863,500 Project Grant to Rutgers, The State University of New Jersey under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning September 1, 2022 will support research into "Genetically Distinct ASD Subtypes: Is MTOR Dysregulation a Common Mechanism?" Through this funding, Rutgers researchers will investigate potential connections between mutations in the MTOR gene pathway and autism...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $934,501 project grant to The Children's Hospital of Philadelphia Research Institute. The grant, titled "Developing Peptide-Centric CARs for NF1-Associated MPNST", will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research aims to develop innovative peptide-based chimeric antigen receptor (CAR) therapies...